Industry Research Reports
Home > Reports > Chemical & Material > Tuna Peptides (L-Anserine) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Tuna Peptides (L-Anserine) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-06-21
Pages: 110 Pages
Report ld: 4770476
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Tuna Peptides (L-Anserine) Market Size(US$)
CAGR 2025-2031
5.4%
Market Size,2031
USD 16.2
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 11.8 million
Market Forecast in 2031(Value)
US$ 16.2 million
CAGR
5.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Tuna Peptides (L-Anserine) was estimated to be worth US$ 11.4 million in 2024 and is forecast to a readjusted size of US$ 16.2 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Tuna Peptides (L-Anserine) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Tuna Peptides (L-Anserine) is a highly active dipeptide (β-alanyl-L-histidine) extracted from the dark muscle tissue of deep-sea tuna (such as bluefin tuna and yellowfin tuna) through bio-enzymatic hydrolysis technology. Its core functions include lowering uric acid, anti-oxidation, anti-glycation and anti-fatigue.
North American market for Tuna Peptides (L-Anserine) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tuna Peptides (L-Anserine) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Tuna Peptides (L-Anserine) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Tuna Peptides (L-Anserine) include Yaizu Suisankagaku Industry, Beyond Biopharma, Lankun, Rongcheng Lanrun Biological Technology, Natide (Yangjiang) Biotechnology, Guangdong Shinyee Marine Biology Engineering, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Tuna Peptides (L-Anserine), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tuna Peptides (L-Anserine) by region & country, by Type, and by Application.
The Tuna Peptides (L-Anserine) market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuna Peptides (L-Anserine).
MARKET SEGMENTATION
By Company
- Yaizu Suisankagaku Industry
- Beyond Biopharma
- Lankun
- Rongcheng Lanrun Biological Technology
- Natide (Yangjiang) Biotechnology
- Guangdong Shinyee Marine Biology Engineering
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Content≥10%
- Content 4%-10%
- Content＜4%
Segment by Application
- Food
- Health Products
- Personal Care
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tuna Peptides (L-Anserine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Tuna Peptides (L-Anserine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Tuna Peptides (L-Anserine) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Tuna Peptides (L-Anserine) Product Introduction
1.2 Global Tuna Peptides (L-Anserine) Market Size Forecast
1.2.1 Global Tuna Peptides (L-Anserine) Sales Value (2020-2031)
1.2.2 Global Tuna Peptides (L-Anserine) Sales Volume (2020-2031)
1.2.3 Global Tuna Peptides (L-Anserine) Sales Price (2020-2031)
1.3 Tuna Peptides (L-Anserine) Market Trends & Drivers
1.3.1 Tuna Peptides (L-Anserine) Industry Trends
1.3.2 Tuna Peptides (L-Anserine) Market Drivers & Opportunity
1.3.3 Tuna Peptides (L-Anserine) Market Challenges
1.3.4 Tuna Peptides (L-Anserine) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tuna Peptides (L-Anserine) Players Revenue Ranking (2024)
2.2 Global Tuna Peptides (L-Anserine) Revenue by Company (2020-2025)
2.3 Global Tuna Peptides (L-Anserine) Players Sales Volume Ranking (2024)
2.4 Global Tuna Peptides (L-Anserine) Sales Volume by Company Players (2020-2025)
2.5 Global Tuna Peptides (L-Anserine) Average Price by Company (2020-2025)
2.6 Key Manufacturers Tuna Peptides (L-Anserine) Manufacturing Base and Headquarters
2.7 Key Manufacturers Tuna Peptides (L-Anserine) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Tuna Peptides (L-Anserine)
2.9 Tuna Peptides (L-Anserine) Market Competitive Analysis
2.9.1 Tuna Peptides (L-Anserine) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Tuna Peptides (L-Anserine) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuna Peptides (L-Anserine) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Content≥10%
3.1.2 Content 4%-10%
3.1.3 Content＜4%
3.2 Global Tuna Peptides (L-Anserine) Sales Value by Type
3.2.1 Global Tuna Peptides (L-Anserine) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Tuna Peptides (L-Anserine) Sales Value, by Type (2020-2031)
3.2.3 Global Tuna Peptides (L-Anserine) Sales Value, by Type (%) (2020-2031)
3.3 Global Tuna Peptides (L-Anserine) Sales Volume by Type
3.3.1 Global Tuna Peptides (L-Anserine) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Tuna Peptides (L-Anserine) Sales Volume, by Type (2020-2031)
3.3.3 Global Tuna Peptides (L-Anserine) Sales Volume, by Type (%) (2020-2031)
3.4 Global Tuna Peptides (L-Anserine) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food
4.1.2 Health Products
4.1.3 Personal Care
4.1.4 Other
4.2 Global Tuna Peptides (L-Anserine) Sales Value by Application
4.2.1 Global Tuna Peptides (L-Anserine) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Tuna Peptides (L-Anserine) Sales Value, by Application (2020-2031)
4.2.3 Global Tuna Peptides (L-Anserine) Sales Value, by Application (%) (2020-2031)
4.3 Global Tuna Peptides (L-Anserine) Sales Volume by Application
4.3.1 Global Tuna Peptides (L-Anserine) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Tuna Peptides (L-Anserine) Sales Volume, by Application (2020-2031)
4.3.3 Global Tuna Peptides (L-Anserine) Sales Volume, by Application (%) (2020-2031)
4.4 Global Tuna Peptides (L-Anserine) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Tuna Peptides (L-Anserine) Sales Value by Region
5.1.1 Global Tuna Peptides (L-Anserine) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Tuna Peptides (L-Anserine) Sales Value by Region (2020-2025)
5.1.3 Global Tuna Peptides (L-Anserine) Sales Value by Region (2026-2031)
5.1.4 Global Tuna Peptides (L-Anserine) Sales Value by Region (%), (2020-2031)
5.2 Global Tuna Peptides (L-Anserine) Sales Volume by Region
5.2.1 Global Tuna Peptides (L-Anserine) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Tuna Peptides (L-Anserine) Sales Volume by Region (2020-2025)
5.2.3 Global Tuna Peptides (L-Anserine) Sales Volume by Region (2026-2031)
5.2.4 Global Tuna Peptides (L-Anserine) Sales Volume by Region (%), (2020-2031)
5.3 Global Tuna Peptides (L-Anserine) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Tuna Peptides (L-Anserine) Sales Value, 2020-2031
5.4.2 North America Tuna Peptides (L-Anserine) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Tuna Peptides (L-Anserine) Sales Value, 2020-2031
5.5.2 Europe Tuna Peptides (L-Anserine) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Tuna Peptides (L-Anserine) Sales Value, 2020-2031
5.6.2 Asia Pacific Tuna Peptides (L-Anserine) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Tuna Peptides (L-Anserine) Sales Value, 2020-2031
5.7.2 South America Tuna Peptides (L-Anserine) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Tuna Peptides (L-Anserine) Sales Value, 2020-2031
5.8.2 Middle East & Africa Tuna Peptides (L-Anserine) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tuna Peptides (L-Anserine) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Tuna Peptides (L-Anserine) Sales Value and Sales Volume
6.2.1 Key Countries/Regions Tuna Peptides (L-Anserine) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Tuna Peptides (L-Anserine) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Tuna Peptides (L-Anserine) Sales Value, 2020-2031
6.3.2 United States Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Tuna Peptides (L-Anserine) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Tuna Peptides (L-Anserine) Sales Value, 2020-2031
6.4.2 Europe Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Tuna Peptides (L-Anserine) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Tuna Peptides (L-Anserine) Sales Value, 2020-2031
6.5.2 China Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Tuna Peptides (L-Anserine) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Tuna Peptides (L-Anserine) Sales Value, 2020-2031
6.6.2 Japan Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Tuna Peptides (L-Anserine) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Tuna Peptides (L-Anserine) Sales Value, 2020-2031
6.7.2 South Korea Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Tuna Peptides (L-Anserine) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Tuna Peptides (L-Anserine) Sales Value, 2020-2031
6.8.2 Southeast Asia Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Tuna Peptides (L-Anserine) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Tuna Peptides (L-Anserine) Sales Value, 2020-2031
6.9.2 India Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Tuna Peptides (L-Anserine) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Yaizu Suisankagaku Industry
7.1.1 Yaizu Suisankagaku Industry Company Information
7.1.2 Yaizu Suisankagaku Industry Introduction and Business Overview
7.1.3 Yaizu Suisankagaku Industry Tuna Peptides (L-Anserine) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Yaizu Suisankagaku Industry Tuna Peptides (L-Anserine) Product Offerings
7.1.5 Yaizu Suisankagaku Industry Recent Development
7.2 Beyond Biopharma
7.2.1 Beyond Biopharma Company Information
7.2.2 Beyond Biopharma Introduction and Business Overview
7.2.3 Beyond Biopharma Tuna Peptides (L-Anserine) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Beyond Biopharma Tuna Peptides (L-Anserine) Product Offerings
7.2.5 Beyond Biopharma Recent Development
7.3 Lankun
7.3.1 Lankun Company Information
7.3.2 Lankun Introduction and Business Overview
7.3.3 Lankun Tuna Peptides (L-Anserine) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Lankun Tuna Peptides (L-Anserine) Product Offerings
7.3.5 Lankun Recent Development
7.4 Rongcheng Lanrun Biological Technology
7.4.1 Rongcheng Lanrun Biological Technology Company Information
7.4.2 Rongcheng Lanrun Biological Technology Introduction and Business Overview
7.4.3 Rongcheng Lanrun Biological Technology Tuna Peptides (L-Anserine) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Rongcheng Lanrun Biological Technology Tuna Peptides (L-Anserine) Product Offerings
7.4.5 Rongcheng Lanrun Biological Technology Recent Development
7.5 Natide (Yangjiang) Biotechnology
7.5.1 Natide (Yangjiang) Biotechnology Company Information
7.5.2 Natide (Yangjiang) Biotechnology Introduction and Business Overview
7.5.3 Natide (Yangjiang) Biotechnology Tuna Peptides (L-Anserine) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Natide (Yangjiang) Biotechnology Tuna Peptides (L-Anserine) Product Offerings
7.5.5 Natide (Yangjiang) Biotechnology Recent Development
7.6 Guangdong Shinyee Marine Biology Engineering
7.6.1 Guangdong Shinyee Marine Biology Engineering Company Information
7.6.2 Guangdong Shinyee Marine Biology Engineering Introduction and Business Overview
7.6.3 Guangdong Shinyee Marine Biology Engineering Tuna Peptides (L-Anserine) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Guangdong Shinyee Marine Biology Engineering Tuna Peptides (L-Anserine) Product Offerings
7.6.5 Guangdong Shinyee Marine Biology Engineering Recent Development
8 Industry Chain Analysis
8.1 Tuna Peptides (L-Anserine) Industrial Chain
8.2 Tuna Peptides (L-Anserine) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tuna Peptides (L-Anserine) Sales Model
8.5.2 Sales Channel
8.5.3 Tuna Peptides (L-Anserine) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Tuna Peptides (L-Anserine) Market Trends
Table 2. Tuna Peptides (L-Anserine) Market Drivers & Opportunity
Table 3. Tuna Peptides (L-Anserine) Market Challenges
Table 4. Tuna Peptides (L-Anserine) Market Restraints
Table 5. Global Tuna Peptides (L-Anserine) Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Tuna Peptides (L-Anserine) Revenue Market Share by Company (2020-2025)
Table 7. Global Tuna Peptides (L-Anserine) Sales Volume by Company (2020-2025) & (kg)
Table 8. Global Tuna Peptides (L-Anserine) Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Tuna Peptides (L-Anserine) Price by Company (2020-2025) & (US$/kg)
Table 10. Key Manufacturers Tuna Peptides (L-Anserine) Manufacturing Base and Headquarters
Table 11. Key Manufacturers Tuna Peptides (L-Anserine) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Tuna Peptides (L-Anserine)
Table 13. Global Tuna Peptides (L-Anserine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuna Peptides (L-Anserine) as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Tuna Peptides (L-Anserine) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Tuna Peptides (L-Anserine) Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Tuna Peptides (L-Anserine) Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Tuna Peptides (L-Anserine) Sales Market Share in Value by Type (2020-2025)
Table 20. Global Tuna Peptides (L-Anserine) Sales Market Share in Value by Type (2026-2031)
Table 21. Global Tuna Peptides (L-Anserine) Sales Volume by Type: 2020 VS 2024 VS 2031 (kg)
Table 22. Global Tuna Peptides (L-Anserine) Sales Volume by Type (2020-2025) & (kg)
Table 23. Global Tuna Peptides (L-Anserine) Sales Volume by Type (2026-2031) & (kg)
Table 24. Global Tuna Peptides (L-Anserine) Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Tuna Peptides (L-Anserine) Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Tuna Peptides (L-Anserine) Price by Type (2020-2025) & (US$/kg)
Table 27. Global Tuna Peptides (L-Anserine) Price by Type (2026-2031) & (US$/kg)
Table 28. Global Tuna Peptides (L-Anserine) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Tuna Peptides (L-Anserine) Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Tuna Peptides (L-Anserine) Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Tuna Peptides (L-Anserine) Sales Market Share in Value by Application (2020-2025)
Table 32. Global Tuna Peptides (L-Anserine) Sales Market Share in Value by Application (2026-2031)
Table 33. Global Tuna Peptides (L-Anserine) Sales Volume by Application: 2020 VS 2024 VS 2031 (kg)
Table 34. Global Tuna Peptides (L-Anserine) Sales Volume by Application (2020-2025) & (kg)
Table 35. Global Tuna Peptides (L-Anserine) Sales Volume by Application (2026-2031) & (kg)
Table 36. Global Tuna Peptides (L-Anserine) Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Tuna Peptides (L-Anserine) Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Tuna Peptides (L-Anserine) Price by Application (2020-2025) & (US$/kg)
Table 39. Global Tuna Peptides (L-Anserine) Price by Application (2026-2031) & (US$/kg)
Table 40. Global Tuna Peptides (L-Anserine) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Tuna Peptides (L-Anserine) Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Tuna Peptides (L-Anserine) Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Tuna Peptides (L-Anserine) Sales Value by Region (2020-2025) & (%)
Table 44. Global Tuna Peptides (L-Anserine) Sales Value by Region (2026-2031) & (%)
Table 45. Global Tuna Peptides (L-Anserine) Sales Volume by Region (kg): 2020 VS 2024 VS 2031
Table 46. Global Tuna Peptides (L-Anserine) Sales Volume by Region (2020-2025) & (kg)
Table 47. Global Tuna Peptides (L-Anserine) Sales Volume by Region (2026-2031) & (kg)
Table 48. Global Tuna Peptides (L-Anserine) Sales Volume by Region (2020-2025) & (%)
Table 49. Global Tuna Peptides (L-Anserine) Sales Volume by Region (2026-2031) & (%)
Table 50. Global Tuna Peptides (L-Anserine) Average Price by Region (2020-2025) & (US$/kg)
Table 51. Global Tuna Peptides (L-Anserine) Average Price by Region (2026-2031) & (US$/kg)
Table 52. Key Countries/Regions Tuna Peptides (L-Anserine) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Tuna Peptides (L-Anserine) Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Tuna Peptides (L-Anserine) Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Tuna Peptides (L-Anserine) Sales Volume, (2020-2025) & (kg)
Table 56. Key Countries/Regions Tuna Peptides (L-Anserine) Sales Volume, (2026-2031) & (kg)
Table 57. Yaizu Suisankagaku Industry Company Information
Table 58. Yaizu Suisankagaku Industry Introduction and Business Overview
Table 59. Yaizu Suisankagaku Industry Tuna Peptides (L-Anserine) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 60. Yaizu Suisankagaku Industry Tuna Peptides (L-Anserine) Product Offerings
Table 61. Yaizu Suisankagaku Industry Recent Development
Table 62. Beyond Biopharma Company Information
Table 63. Beyond Biopharma Introduction and Business Overview
Table 64. Beyond Biopharma Tuna Peptides (L-Anserine) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 65. Beyond Biopharma Tuna Peptides (L-Anserine) Product Offerings
Table 66. Beyond Biopharma Recent Development
Table 67. Lankun Company Information
Table 68. Lankun Introduction and Business Overview
Table 69. Lankun Tuna Peptides (L-Anserine) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 70. Lankun Tuna Peptides (L-Anserine) Product Offerings
Table 71. Lankun Recent Development
Table 72. Rongcheng Lanrun Biological Technology Company Information
Table 73. Rongcheng Lanrun Biological Technology Introduction and Business Overview
Table 74. Rongcheng Lanrun Biological Technology Tuna Peptides (L-Anserine) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 75. Rongcheng Lanrun Biological Technology Tuna Peptides (L-Anserine) Product Offerings
Table 76. Rongcheng Lanrun Biological Technology Recent Development
Table 77. Natide (Yangjiang) Biotechnology Company Information
Table 78. Natide (Yangjiang) Biotechnology Introduction and Business Overview
Table 79. Natide (Yangjiang) Biotechnology Tuna Peptides (L-Anserine) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 80. Natide (Yangjiang) Biotechnology Tuna Peptides (L-Anserine) Product Offerings
Table 81. Natide (Yangjiang) Biotechnology Recent Development
Table 82. Guangdong Shinyee Marine Biology Engineering Company Information
Table 83. Guangdong Shinyee Marine Biology Engineering Introduction and Business Overview
Table 84. Guangdong Shinyee Marine Biology Engineering Tuna Peptides (L-Anserine) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 85. Guangdong Shinyee Marine Biology Engineering Tuna Peptides (L-Anserine) Product Offerings
Table 86. Guangdong Shinyee Marine Biology Engineering Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Tuna Peptides (L-Anserine) Downstream Customers
Table 90. Tuna Peptides (L-Anserine) Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuna Peptides (L-Anserine) Product Picture
Figure 2. Global Tuna Peptides (L-Anserine) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Tuna Peptides (L-Anserine) Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Tuna Peptides (L-Anserine) Sales Volume (2020-2031) & (kg)
Figure 5. Global Tuna Peptides (L-Anserine) Sales Price (2020-2031) & (US$/kg)
Figure 6. Tuna Peptides (L-Anserine) Report Years Considered
Figure 7. Global Tuna Peptides (L-Anserine) Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Tuna Peptides (L-Anserine) Players Sales Volume Ranking (2024) & (kg)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tuna Peptides (L-Anserine) Revenue in 2024
Figure 10. Tuna Peptides (L-Anserine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Content≥10% Picture
Figure 12. Content 4%-10% Picture
Figure 13. Content＜4% Picture
Figure 14. Global Tuna Peptides (L-Anserine) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Tuna Peptides (L-Anserine) Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Tuna Peptides (L-Anserine) Sales Volume by Type (2020 VS 2024 VS 2031) & (kg)
Figure 17. Global Tuna Peptides (L-Anserine) Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Tuna Peptides (L-Anserine) Price by Type (2020-2031) & (US$/kg)
Figure 19. Product Picture of Food
Figure 20. Product Picture of Health Products
Figure 21. Product Picture of Personal Care
Figure 22. Product Picture of Other
Figure 23. Global Tuna Peptides (L-Anserine) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 24. Global Tuna Peptides (L-Anserine) Sales Value Market Share by Application, 2024 & 2031
Figure 25. Global Tuna Peptides (L-Anserine) Sales Volume by Application (2020 VS 2024 VS 2031) & (kg)
Figure 26. Global Tuna Peptides (L-Anserine) Sales Volume Market Share by Application, 2024 & 2031
Figure 27. Global Tuna Peptides (L-Anserine) Price by Application (2020-2031) & (US$/kg)
Figure 28. North America Tuna Peptides (L-Anserine) Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Tuna Peptides (L-Anserine) Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Tuna Peptides (L-Anserine) Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Tuna Peptides (L-Anserine) Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Tuna Peptides (L-Anserine) Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Tuna Peptides (L-Anserine) Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Tuna Peptides (L-Anserine) Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Tuna Peptides (L-Anserine) Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Tuna Peptides (L-Anserine) Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Tuna Peptides (L-Anserine) Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Tuna Peptides (L-Anserine) Sales Value (%), (2020-2031)
Figure 39. Key Countries/Regions Tuna Peptides (L-Anserine) Sales Volume (%), (2020-2031)
Figure 40. United States Tuna Peptides (L-Anserine) Sales Value, (2020-2031) & (US$ Million)
Figure 41. United States Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
Figure 42. United States Tuna Peptides (L-Anserine) Sales Value by Application (%), 2024 VS 2031
Figure 43. Europe Tuna Peptides (L-Anserine) Sales Value, (2020-2031) & (US$ Million)
Figure 44. Europe Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
Figure 45. Europe Tuna Peptides (L-Anserine) Sales Value by Application (%), 2024 VS 2031
Figure 46. China Tuna Peptides (L-Anserine) Sales Value, (2020-2031) & (US$ Million)
Figure 47. China Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
Figure 48. China Tuna Peptides (L-Anserine) Sales Value by Application (%), 2024 VS 2031
Figure 49. Japan Tuna Peptides (L-Anserine) Sales Value, (2020-2031) & (US$ Million)
Figure 50. Japan Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
Figure 51. Japan Tuna Peptides (L-Anserine) Sales Value by Application (%), 2024 VS 2031
Figure 52. South Korea Tuna Peptides (L-Anserine) Sales Value, (2020-2031) & (US$ Million)
Figure 53. South Korea Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
Figure 54. South Korea Tuna Peptides (L-Anserine) Sales Value by Application (%), 2024 VS 2031
Figure 55. Southeast Asia Tuna Peptides (L-Anserine) Sales Value, (2020-2031) & (US$ Million)
Figure 56. Southeast Asia Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
Figure 57. Southeast Asia Tuna Peptides (L-Anserine) Sales Value by Application (%), 2024 VS 2031
Figure 58. India Tuna Peptides (L-Anserine) Sales Value, (2020-2031) & (US$ Million)
Figure 59. India Tuna Peptides (L-Anserine) Sales Value by Type (%), 2024 VS 2031
Figure 60. India Tuna Peptides (L-Anserine) Sales Value by Application (%), 2024 VS 2031
Figure 61. Tuna Peptides (L-Anserine) Industrial Chain
Figure 62. Tuna Peptides (L-Anserine) Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Tuna Peptides (L-Anserine) in 2025?
The global market size of Tuna Peptides (L-Anserine) in 2025 was 11.8 Million USD.
What is the annual compound growth rate of the global Tuna Peptides (L-Anserine) market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Tuna Peptides (L-Anserine) in 2031?
Which companies rank high in the global Tuna Peptides (L-Anserine) market?
Related Reports
Global Tuna Peptides (L-Anserine) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Tuna Peptides (L-Anserine) market is projected to grow from US$ 11.82 million in 2025 to US$ 16.99 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 144
USD 4900.00
(Single User License)
Global Tuna Peptides (L-Anserine) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Tuna Peptides (L-Anserine) market size was US$ 11.82 million in 2025 and is forecast to reach a readjusted size of US$ 16.99 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 77
USD 4250.00
(Single User License)
Global Tuna Peptides (L-Anserine) Market Research Report 2026
The global Tuna Peptides (L-Anserine) market was valued at US$ 11.82 million in 2025 and is anticipated to reach US$ 16.99 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 130
USD 2900.00
(Single User License)
Tuna Peptides (L-Anserine)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tuna Peptides (L-Anserine) was estimated to be worth US$ 11.82 million in 2025 and is projected to reach US$ 16.99 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 108
USD 3950.00
(Single User License)
Global Tuna Peptides (L-Anserine) Market Research Report 2025
The global market for Tuna Peptides (L-Anserine) was valued at US$ 11.4 million in the year 2024 and is projected to reach a revised size of US$ 16.2 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-06-21
Pages: 90
USD 2900.00
(Single User License)
Global Tuna Peptides (L-Anserine) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tuna Peptides (L-Anserine) market size was US$ 11.4 million in 2024 and is forecast to a readjusted size of US$ 16.2 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-06-21
Pages: 78
USD 4250.00
(Single User License)
Global Tuna Peptides (L-Anserine) Market Insights, Forecast to 2031
The global Tuna Peptides (L-Anserine) market is projected to grow from US$ 11.8 million in 2025 to US$ 16.2 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.
Published Date: 2025-06-21
Pages: 146
USD 4900.00
(Single User License)
Global Tuna Peptides (L-Anserine) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Tuna Peptides (L-Anserine) market is projected to grow from US$ 11.82 million in 2025 to US$ 16.99 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 144
USD 4900.00 (Single User License)Global Tuna Peptides (L-Anserine) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Tuna Peptides (L-Anserine) market size was US$ 11.82 million in 2025 and is forecast to reach a readjusted size of US$ 16.99 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 77
USD 4250.00 (Single User License)Global Tuna Peptides (L-Anserine) Market Research Report 2026
The global Tuna Peptides (L-Anserine) market was valued at US$ 11.82 million in 2025 and is anticipated to reach US$ 16.99 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-03-12
Pages: 130
USD 2900.00 (Single User License)Tuna Peptides (L-Anserine)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tuna Peptides (L-Anserine) was estimated to be worth US$ 11.82 million in 2025 and is projected to reach US$ 16.99 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-03-09
Pages: 108
USD 3950.00 (Single User License)Global Tuna Peptides (L-Anserine) Market Research Report 2025
The global market for Tuna Peptides (L-Anserine) was valued at US$ 11.4 million in the year 2024 and is projected to reach a revised size of US$ 16.2 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-06-21
Pages: 90
USD 2900.00 (Single User License)Global Tuna Peptides (L-Anserine) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tuna Peptides (L-Anserine) market size was US$ 11.4 million in 2024 and is forecast to a readjusted size of US$ 16.2 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-06-21
Pages: 78
USD 4250.00 (Single User License)Global Tuna Peptides (L-Anserine) Market Insights, Forecast to 2031
The global Tuna Peptides (L-Anserine) market is projected to grow from US$ 11.8 million in 2025 to US$ 16.2 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.
Published: 2025-06-21
Pages: 146
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now